Diffuse Bio
YC W23San Francisco, US · Founded 2022 · 10 employees · 2 known investors
Diffuse designs proteins using AI models trained on experimental data collected through proprietary assays and software, delivering validated AI-designed proteins to partners.
AI & Machine LearningBiotechDeep TechHealthtechAI-powered Drug DiscoveryDeep LearningGenerative AIMachine Learningin /company@ycombinator
Founders & leadership· Y Combinator alumni (W23)
Namrata AnandinFounder
Investors · 2
In the news
- Scientists use new A.I. tech to fight diseases - YouTubeyoutube.com · 2023
- Diffuse Bio - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2023
- Diffuse Bio - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2023
- A.I. Turns Its Artistry to Creating New Human Proteins - The New York Timesnytimes.com · 2023
- Diffuse Bio Funding | $1.5M Revenue | Complete Analysis | Extruct AIextruct.ai